Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ocugen Inc. buy BiotechBee

Ocugen Inc.
Start price
€1.63
26.05.24 / 50%
Target price
€3.50
28.02.26
Performance (%)
-49.35%
End price
€0.82
14.12.24
Summary
This prediction ended on 14.12.24 with a price of €0.82. The BUY prediction by BiotechBee for Ocugen Inc. performed very badly with a performance of -49.35%. BiotechBee has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Ocugen Inc. 5.435% 5.435% 30.993%
iShares Core DAX® 0,44 % 5,64 % 7,81 %
iShares Nasdaq 100 1,06 % 0,28 % 27,24 %
iShares Nikkei 225® 1,77 % 0,41 % 49,27 %
iShares S&P 500 0,37 % 1,92 % 22,34 %

According to BiotechBee what are the pros and cons of Ocugen Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Ocugen Inc. diskutieren
Prediction Buy
Perf. (%) -49.35%
Target price 3.500
Change
Ends at 28.02.26

Buy mit Kursziel 3,5

BiotechBee 
0
Report Share
26.05.24
In the thread Trading Ocugen Inc.
Prediction Buy
Perf. (%) -49.35%
Target price 3.500
Change
Ends at 28.02.26

Buy beendet

BiotechBee 
0
Report Share
14.12.24